Plus   Neg

Stock Alert: Harley-Davidson Falls 9% As Q2 Results Miss Expectations

Shares of Harley-Davidson, Inc. (HOG) are losing more than 9 percent or $2.66 in Tuesday's morning trade at $26.62 after the motorcycle maker's second-quarter results missed analysts' expectations.

Tuesday, Harley-Davidson reported second-quarter net loss of $92.22 million or $0.60 per share, compared to net income of $195.63 million or $1.23 per share in the same period last year. Adjusted loss was $0.35 per share, while the average estimate of analysts polled by Thomson Reuters was for earnings of $0.03 per share.

Motorcycles and related products revenue fell to $669.27 million from $1.43 billion a year ago. The Street expected revenues of $808.46 million.

The company said it is not providing financial outlook for fiscal 2020 due to the uncertainty surrounding the impact of the COVID-19 pandemic.

Harley-Davidson has traded in a range of $14.31 to $40.89 in the past 52 weeks.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Despite the coronavirus pandemic, retailers are prepared for an early start to the holiday shopping season by offering discounts earlier so that consumers can buy and receive the gifts they want in time, the National Retail Federation or NRF said. The NRF also said it is launching a nationwide consumer education campaign called "New Holiday Traditions". Facebook (FB) has revealed new messaging features for Instagram, which will make it easier for users to stay in touch with others across Facebook's family of apps. The main change is that people using the Messenger app can now reach Instagram users, and vice versa. The users can control where they receive... Regeneron Pharmaceuticals, Inc. announced positive first data from a descriptive analysis of a seamless Phase 1/2/3 trial of its investigational antibody cocktail REGN-COV2 in COVID-19 patients. REGN-COV2 rapidly reduced viral load and associated symptoms in infected COVID-19 patients. The company said it plans rapidly to discuss results with regulatory authorities.
Follow RTT